Ki16425 is a competitive, potent and reversible antagonist to LPA1, LPA2 and LPA3 with Ki of 0.34 ?M, 6.5 ?M and 0.93 ?M in RH7777 cell lines, respectively, shows no activity at LPA4, LPA5, LPA6. *For Research & Development use only. Product is not intended for drug, household, or human consumption.